The efficacy of dolutegravir/lamivudine/tenofovir (Viropil, DTG/3TC/TDF)

Dolutegravir/Lamivudine/Tenofovir (Viropil, Viropil,DTG/3TC/TDF) is a combination drug used to treat human immunodeficiency virus (HIV) infection. Its efficacy is mainly reflected in the following aspects:

1.Inhibition of viral replication: Dolutegravir/Lamivudine/The tenofovir combination includes dolutegravir (integrase chain terminator), lamivudine and tenofovir (nucleoside analog reverse transcriptase inhibitor). These drugs act on HIVHIV through different mechanisms and jointly inhibit the replication and reproduction of the virus. This can help reduce viral load, maintain immune system function, and slow disease progression.

2.IncreaseCD4 cell count: In HIV infected people, CD4 cells are an important part of the immune system. Treatment with dolutegravir/lamivudine/tenofovir can help restore the number of CD4 cells, thereby enhancing immune function and reducing the risk of complications.

3.Maintain viral suppression: Proper use of dolutegravir/Lamivudine/Tenofovir can keep the virus at a low level, that is, a state of viral suppression. This helps reduceHIV related symptoms, maintain patients’ quality of life, and slow the progression of the disease.

4.Reduce the risk of transmission: By effectively inhibiting viral replication, dolutegravir/lamivudine/tenofovir can reduce the risk of HIV being transmitted to others. This is preventionHIV plays an important role in the spread and control of the epidemic.

It should be noted that the efficacy of drugs may vary due to individual differences. At the same time, correct use of medications and following doctor's recommendations are also important factors in ensuring efficacy. The evaluation of the efficacy of dolutegravir/lamivudine/tenofovir should be based on the specific conditions of the patient, and indicators such as viral load and CD4 cell count should be monitored regularly to ensure the sustainability and maximization of the therapeutic effect.

Dolutegravir/Lamivudine/Tenofovir (Viropil, Viropil, DTG/3TC/TDF) is not currently available in the country, so it cannot be purchased domestically and needs to be purchased through foreign channels. The cheaper ones abroad are Indian generic drugs, which cost about 450 yuan.